These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11264790)

  • 1. Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults reflects different courses of beta cell damage.
    Törn C; Landin-Olsson M; Lernmark A; Scherstén B; Ostman J; Arnqvist HJ; Björk E; Blohmé G; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G
    Autoimmunity; 2001; 33(2):115-20. PubMed ID: 11264790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
    Seissler J; Atik Y; Klinghammer A; Scherbaum WA
    Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.
    Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M
    Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus--a nationwide study.
    Ostman J; Landin-Olsson M; Törn C; Palmer J; Lernmark A; Arnqvist H; Björk E; Bolinder J; Blohmé G; Eriksson J; Littorin B; Nyström L; Scherstén B; Sundkvist G; Wibell L
    Diabet Med; 2000 Apr; 17(4):269-74. PubMed ID: 10821292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for the course of beta cell function in autoimmune diabetes.
    Törn C; Landin-Olsson M; Lernmark A; Palmer JP; Arnqvist HJ; Blohmé G; Lithner F; Littorin B; Nyström L; Scherstén B; Sundkvist G; Wibell L; Ostman J
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4619-23. PubMed ID: 11134117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
    Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
    Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
    Sera Y; Kawasaki E; Abiru N; Ozaki M; Abe T; Takino H; Kondo H; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S; Uchigata Y; Matsuura N; Eguchi K
    J Autoimmun; 1999 Sep; 13(2):257-65. PubMed ID: 10479394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus.
    Borg H; Fernlund P; Sundkvist G
    Clin Chem; 1997 Dec; 43(12):2358-63. PubMed ID: 9439455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.
    Savola K; Bonifacio E; Sabbah E; Kulmala P; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Meriläinen J; Akerblom HK; Knip M
    Diabetologia; 1998 Apr; 41(4):424-9. PubMed ID: 9562346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet cell antibodies represent autoimmune response against several antigens.
    Månsson L; Törn C; Landin-Olsson M
    Int J Exp Diabetes Res; 2001; 2(2):85-90. PubMed ID: 12369720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome.
    Morgenthaler NG; Seissler J; Achenbach P; Glawe D; Payton M; Meinck HM; Christie MR; Scherbaum WA
    Autoimmunity; 1997; 25(4):203-11. PubMed ID: 9344328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes.
    Borg H; Gottsäter A; Fernlund P; Sundkvist G
    Diabetes; 2002 Jun; 51(6):1754-62. PubMed ID: 12031962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
    Dittler J; Seidel D; Schenker M; Ziegler AG
    Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes.
    Borg H; Marcus C; Sjöblad S; Fernlund P; Sundkvist G
    Acta Paediatr; 2000 Jan; 89(1):46-51. PubMed ID: 10677057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes.
    Hawa M; Rowe R; Lan MS; Notkins AL; Pozzilli P; Christie MR; Leslie RD
    Diabetes; 1997 Aug; 46(8):1270-5. PubMed ID: 9231650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age.
    Borg H; Gottsäter A; Landin-Olsson M; Fernlund P; Sundkvist G
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3032-8. PubMed ID: 11443164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.